BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29874035)

  • 1. Locally Deployable Nanofiber Patch for Sequential Drug Delivery in Treatment of Primary and Advanced Orthotopic Hepatomas.
    Li J; Xu W; Li D; Liu T; Zhang YS; Ding J; Chen X
    ACS Nano; 2018 Jul; 12(7):6685-6699. PubMed ID: 29874035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination treatment with Rhizoma Paridis and Rhizoma Curcuma longa extracts and 10-hydroxycamptothecin enhances the antitumor effect in H22 tumor model by increasing the plasma concentration.
    Liu Z; Li H; Fan Y; Liu Y; Man S; Yu P; Gao W
    Biomed Pharmacother; 2016 Oct; 83():627-634. PubMed ID: 27459119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positively charged polypeptide nanogel enhances mucoadhesion and penetrability of 10-hydroxycamptothecin in orthotopic bladder carcinoma.
    Guo H; Xu W; Chen J; Yan L; Ding J; Hou Y; Chen X
    J Control Release; 2017 Aug; 259():136-148. PubMed ID: 28062300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
    Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
    J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
    Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
    J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activities of emulsion electrospun fibers with core loading of hydroxycamptothecin via intratumoral implantation.
    Luo X; Xie C; Wang H; Liu C; Yan S; Li X
    Int J Pharm; 2012 Apr; 425(1-2):19-28. PubMed ID: 22265915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimetastasis and antitumor efficacy promoted by sequential release of vascular disrupting and chemotherapeutic agents from electrospun fibers.
    Luo X; Zhang H; Chen M; Wei J; Zhang Y; Li X
    Int J Pharm; 2014 Nov; 475(1-2):438-49. PubMed ID: 25218185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxycamptothecin liposomes based on thermal and magnetic dual-responsive system: preparation, in vitro and in vivo antitumor activity, microdialysis-based tumor pharmacokinetics.
    Zhu HM; Gu JH; Xie Y; Xie B; Ling JJ
    J Drug Target; 2018 Apr; 26(4):345-356. PubMed ID: 28920483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
    Zhu H; Cao J; Cui S; Qian Z; Gu Y
    J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation.
    Luo X; Xu G; Song H; Yang S; Yan S; Jia G; Li X
    Eur J Pharm Biopharm; 2012 Nov; 82(3):545-53. PubMed ID: 22995703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma.
    Yu ZJ; Yu JW; Cai W; Yuan HX; Li XY; Yuan Y; Chen JP; Wu XY; Yao DF
    World J Gastroenterol; 2005 Sep; 11(33):5221-5. PubMed ID: 16127757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of hydroxycamptothecin-encapsulated chitosan nanospheres for the treatment of liver cancer.
    Han J; Hou ZQ; Wang YG; Guo X
    Technol Cancer Res Treat; 2015 Feb; 14(1):111-7. PubMed ID: 24593290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine-mediated hydroxyethyl starch-10-hydroxy camptothecin micelles for the treatment of liver cancer.
    Li G; Zhao M; Zhao L
    Drug Deliv; 2020 Dec; 27(1):519-529. PubMed ID: 32228107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermosensitive injectable hydrogel enhances the antitumor effect of embelin in mouse hepatocellular carcinoma.
    Peng M; Xu S; Zhang Y; Zhang L; Huang B; Fu S; Xue Z; Da Y; Dai Y; Qiao L; Dong A; Zhang R; Meng W
    J Pharm Sci; 2014 Mar; 103(3):965-73. PubMed ID: 24481745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial distribution and antitumor activities after intratumoral injection of fragmented fibers with loaded hydroxycamptothecin.
    Wei J; Luo X; Chen M; Lu J; Li X
    Acta Biomater; 2015 Sep; 23():189-200. PubMed ID: 26013039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine-10-hydroxy camptothecine-loaded lipid microsphere for the synergistic treatment of liver cancer by inhibiting topoisomerase and HIF-1α.
    Qi Y; Liu G
    Drug Deliv; 2021 Dec; 28(1):171-182. PubMed ID: 33427515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin.
    Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X
    Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma.
    Zhang Y; Zhang J; Xu W; Xiao G; Ding J; Chen X
    Acta Biomater; 2018 Sep; 77():63-73. PubMed ID: 30006312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
    Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
    Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.